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INTRODUCTION 
Severe sepsis in children remains a common cause of hospitalization (1). Bacteraemia 
account for 25% of hospitalization for severe bacterial infections, and mortality rate is as high as 17% 
(1). Few temporal changes in the distribution of bacterial species in bloodstream infections have 
been reported (2). In industrialized countries, Streptococcus pneumoniae, Staphylococcus aureus and 
Escherichia coli figure among the 5 more frequently isolated organisms (3).  
E. coli is a commensal bacteria of the gut (4). Some strains can cause however intestinal or 
extra-intestinal infections due to specific virulence factors (5). The structure of E. coli population is 
mainly clonal (6), with seven principal phylogenetic groups (A, B1, B2, C, D, E and F) and numerous 
clonal complexes (4, 7-10). Most clinical extra-intestinal pathogenic E. coli belong to the B2 
phylogroup, and to a lesser extent to the D phylogenetic group (11). Some clones or clonal complexes 
have been linked to specific syndromes (12, 13). 
In adults, mortality of E. coli bacteraemia has been reported to be as high as 13% in a recent 
study performed by our group (14). We showed that host factors and the portal of entry are the main 
drivers of mortality during E. coli bacteraemia. The only bacterial characteristic influencing the 
prognosis was the presence of virulence factor ireA, which was negatively associated with death. 
Phylogenetic belonging of the strains was not a significant predictor.  
Studies of E. coli bloodstream infections in children, especially in urinary-source bacteraemia, 
linked some virulence factors to the development of bacteraemia (15-17). They include adhesins, 
iron uptake systems, protectins and toxins, with differences according to the portal of entry. A higher 
content in virulence factors was thus reported in strains causing urosepsis when compared to strains 
causing urinary-tract infections without bacteraemia (16). However, there is a lack of prospective 
studies taking into account both host and bacterial characteristics versus the clinical outcome of E. 
coli bacteraemia in children.  
To better understand the pathophysiology and severity of E. coli bacteraemia in children, we 
aŶalǇsed the Đohoƌt of ĐhildƌeŶ чϭϴ-year-old of the COLIBAFI study (14). We compared bacterial 
characteristics (i) in bacteraemia from urinary vs. digestiǀe oƌigiŶ, ;iiͿ iŶ ĐhildƌeŶ чϯ vs. >3-month-old, 
and (iii) in community-acquired urinary-source bacteraemia in children vs. adults. Then we searched 
for clinical and bacterial risk factors associated with the severity of E. coli bacteraemia in children.  
MATERIALS AND METHODS 
Study Design and Setting 
This study is part of the COLIBAFI study, a large prospective observational study conducted in 
15 French hospitals between January 2005 and November 2007 in which 1051 adults and 84 children 
with E. coli bacteraemia were enrolled. The methodology has been previously published (14). E. coli 
bacteraemia was defined as the presence of E. coli iŶ шϭ aseptiĐallǇ filled ďlood Đultuƌe ǀial;sͿ. The 
follow-up ended at hospital discharge, or at day 28 after the first positive blood culture. The study 
was approved by the institutional Ethics Committee (Hôpital Saint-Louis, Paris, France). 
Clinical and Bacterial Characteristics 
Clinical characteristics included age, gender, birth weight, preterm birth, immunodepression 
and origin of infection. Portal of entry, immunodepression and nosocomial bacteraemia were 
defined as in (14). Severity of bacteraemia was defined as the occurrence of death or transfer to ICU 
during follow-up. 
Phylogenetic group of strains was determined by a quadruplex PCR method derived from the 
Clermont method (18), associated to allele specific PCRs allowing the delineation of 7 main 
phylogroups (i.e., A, B1, B2, C, D, E and F) (19). Strains exhibiting the A1 genotype (chuA-, yjaA+, 
TspE4.C2-) (18) correspond to ST complex (STc) 10 according to the Achtman multilocus sequence 
typing (MLST) scheme (9). Among the D phylogroup strains, clonal group A (CGA) was identified as 
previously described (20). Ten main B2 phylogenetic subgroups (I to X) were detected by allele 
specific PCRs (8, 21). They correspond to STc 131, 73, 127, 141, 144, 12, 14, 452, 95 and 372, 
respectively (9). O-typing was performed by PCR (22, 23). 
The presence of 20 extraintestinal virulence factors was tested by PCR (14, 24), including 
adhesins/invasins (papC, papG II and III alleles, sfa/foc, iha, hra, and ibeA), toxins (hlyC, cnf1, sat, clbA 
and clbQ), iron capture systems (fyuA, irp2, iroN, iucC, and ireA), protectins (neuC, chromosomal 
ompT, and traT), and a gene encoding an uropathogenic-specific protein, usp. The presence of 5 
intestinal virulence genes was also tested by PCR (23): afaD (diffusely adherent E. coli=DAEC), eltB 
and estA (enterotoxigenic E. coli=ETEC), eae (enteropathogenic E. coli=EPEC and enterohemorrhagic 
E. coli=EHEC) and aatA (enteroaggregative E. coli=EAEC). The presence of 7 pathogenicity-associated 
islands (PAIs) was deduced from the presence of virulence factors (25, 26): PAI ICFT073 (papGII, hlyC, 
and iucC positive), PAI IIJ96 (presence of at least 3 of the 4 following genes: papGIII, hlyC, cnf1, and 
hra), PAI III536 (sfa/foc and iroN positive), PAI IV536 (irp2 and fyuA positive), PAIgimA (ibeA positive), 
PAIUSP (usp positive) and PAIpks (clbA and clbQ positive). For each strain, virulence and PAIs scores 
were computed as the number of virulence factors and PAIs present. 
Antimicrobial susceptibility was assessed using the disk diffusion method, as recommended 
by the Comité de l’AŶtiďiogƌaŵŵe de la “oĐiété FƌaŶçaise de MiĐƌoďiologie ;ǁǁǁ.sfŵ-
microbiologie.org). Intermediate susceptibility was regarded as resistance. Resistance to cefotaxime 
and/or ceftazidime defined resistance to third-generation cephalosporin. Resistance to amoxicillin, 
ofloxacin and cotrimoxazole defined multidrug resistance. A resistance score was computed based on 
resistance to amoxicillin, cefotaxime, gentamicin, ofloxacin and cotrimoxazole. 
Statistical Methods 
We compared bacterial characteristics i) in bacteraemia from urinary vs. digestive origin, ii) in 
children ч3 vs. >3-month-old, iii) in children vs. adults presenting a community-acquired urinary-
source bacteraemia. The cut-off of 3 months was chosen as the first 3 months of life correspond to a 
period of age with a known increased risk of E. coli bacteraemia and meningitis related to the 
impaired innate immunity in this period (27, 28). For the third comparison, all adults from the 
COLIBAFI cohort presenting a community-acquired urinary-source bacteraemia were included. 
Characteristics tested included phylogenetic group (from the results of the triplex PCR (18), grouped 
as B2 vs. non-B2), virulence factors and PAIs, virulence and PAI scores, antimicrobial resistance, 
multidrug resistance, and resistance score. Comparisons between groups were performed using non-
parametric tests (Wilcoxon or Fisher exact tests). 
We searched for risk factors associated with severity (yes/no). Analyses were performed in 
all ĐhildƌeŶ aŶd iŶ the чϯ-month-old subgroup. Clinical characteristics studied included gender, age 
(ч3 vs. >3-month-old), immunodepression, nosocomial infection and portal of entry. Prematurity and 
birth weight were also studied in ч3-month-old infants. The same bacterial characteristics than those 
described above were analyzed. Variables achieving a p-value <0.20 in univariate logistic regression 
analysis were entered into a multivariate logistic regression analysis to identify risk factors of 
severity. Using a forward selection method, we obtained a final model in which all risk factors had a 
p-value <0.05. First order interaction was tested for significant variables. The model discrimination 
was assessed by the c-statistic and its 95% confidence interval (95%CI), and the model calibration 
was assessed by the Hosmer-Lemeshow goodness-of-fit test.  
Analyses were performed with SAS v9.3 (SAS Institute Inc., Cary, NC). All tests were two-sided 
with a type-I error fixed to 0.05. 
RESULTS 
Clinical Characteristics 
All 84 patients ч18-year-old from the COLIBAFI cohort were included (Table 1). The most 
frequent portals of entry were the urinary tract (n=51, 66.2%) and the digestive tract (n=15, 19.5%). 
Eight children (10.4%) were immunocompromized: 4 had a history of hemopathy, 2 had had solid-
organ transplantation, 1 had neutropenia and 1 had a congenital immunodeficiency. Fourteen 
children (16.7%) were transferred to ICU, 8 (9.5%) died during follow-up. In total, 17 (20.2%) 
presented a severe bacteraemia (95%CI, 12.2% - 30.4%).  
Bacterial Characteristics 
Three children had a polymicrobial bacteraemia. The most frequent E. coli phylogenetic 
group was B2 group (63.1%), followed by D, F and A groups (11.9%, 9.5% and 8.3%, respectively). No 
strain belonged to the E phylogenetic group. Among the B2 isolates, most represented clonal groups 
were the II (STc73) and IX (STc95) subgroups (37.7% for each group). Other clonal groups were I, IV, 
V, VI, VII and X groups (5.6%, 9.4%, 1.9%, 1.9%, 3.8% and 1.9%, respectively). All except 3 strains from 
the D phylogroup corresponded to the CGA. Three among the 7 strains of phylogroup A belonged to 
the STc10. Only 3 strains were not O-typed. Four O-types were predominant: O6a (20.2%), O1 
(19.0%), O2a and O2b (15.4%) and O7 (8.3%). Individual data for phylogenetic groups, clonal groups 
and O-types are presented in Supplemental Digital Content 1 (Table S1). 
The proportion of extraintestinal virulence factors ranged from 6.0% for ibeA to 94.1% for 
fyuA and irp2 (see Table S1 in Supplemental Digital Content 1 and Figure S1 in Supplemental Digital 
Content 2). Likely, the frequency of PAIs ranged from 6.0% for the PAIgimA to 94.1% for the PAI IV536, 
with frequencies of 17.9%, 25.0%, 27.4%, 32.1% and 65.5% for PAI IIJ96, PAI ICFT073, PAI III536, PAIpks and 
PAIUSP, respectively. Median (min-max) virulence and PAI scores were 12 (1-9) and 2 (0-7), 
respectively. Only one strain belonging to the A1 clonal group (STc10) exhibited intraintestinal 
virulence genes, i.e. afaD and aatA. Most isolates were resistant to amoxicillin (63.1%) and 
susceptible to ofloxacin and gentamicin (96.4% and 96.4%, Figure S1). Three isolates were resistant 
to third-generation cephalosporins (3.6%) but none to imipenem, and 29 (34.5%) were resistant to 
cotrimoxazole. Three isolates (3.6%) were multidrug resistant. 
Comparison of urinary vs. digestive origin 
The aerobactin gene iucC, the papGII allele and the PAI ICFT073 were more frequent in strains 
responsible of bacteraemia from urinary origin than from digestive origin (p=0.003, p=0.03 and 
p=0.05, respectively). There was no difference in phylogroup repartition or antimicrobial 
susceptibility according to portal of entry (Table 2). 
Comparison of ≤3 vs. >3-Month-Old Children 
ChildƌeŶ чϯ-month-old (n=43, 51%) were more frequently males than patients >3-month-old 
(72.1% vs. 41.5%, p<0.01) and less frequently immunocompromized (0.0% vs. 21.1%, p=0.002). There 
was no significant difference found in portals of entry. Severe bacteraemia were more frequently 
oďseƌǀed iŶ ĐhildƌeŶ чϯ-month-old (32.6% vs. ϳ.ϯ%, p=Ϭ.ϬϬϲͿ. ThiƌteeŶ ĐhildƌeŶ чϯ-month-old and 1 
children >3-month-old were transferred to ICU, ǁhile ϲ ĐhildƌeŶ чϯ-month-old and 2 children >3-
month-old died during follow-up. Bacterial characteristics are reported in Table 3. Virulence score 
ǁas higheƌ iŶ чϯ-month-old children (median [min-max] = 15 (5-18] vs. 10 [1-19], p=0.02), with 3 
virulence factors being more frequently observed: neuC (K1 antigen, 55.8% vs. 26.8%, p=0.009), irp2 
(100% vs. 87.8%, p=0.02) and fyuA (100% vs. 87.8%, p=0.02). Antimicrobial resistance score was 
loǁeƌ iŶ чϯ-month-old infants (median [min-max] = 1 [0-4] vs. 1 [0-5], p=0.01), with lower rates of 
resistance to amoxicillin (51.2% vs. 75.6%, p=0.02) and cotrimoxazole (23.3% vs. 46.3%, p=0.04). 
Children vs. Adults Community-Acquired Urinary-Source Bacteraemia 
Community-acquired urinary-source bacteraemia concerned 45 children and 513 adults from 
the COLIBAFI cohort (Table 4). We observed more females (73.1% vs. 44.4%, p<0.001) and a higher 
rate of immunodepression in adults than in children (23.9% vs. 4.9 %, p=0.003). Severe bacteraemia 
was more frequent in adults (11.9% vs. 0%, p=0.01). There was no significant difference in 
phylogenetic groups (B2 vs. non-B2) nor in virulence scores, but 5 virulence factors were significantly 
more frequent in E. coli strains isolated from children (i.e., iucC, iha, papC, papGII and sat), whereas 
hra was significantly less frequent. Adult isolates had a higher resistance score (median [min-max] = 1 
[0-5] vs. 1 [0-4], p=0.04). 
Risk Factors of Severity 
Results of the univariate and multivariate analyses to identify risk factors of severity in all the 
included children are reported Table 5. Because of some missing characteristics, the multivariate 
analysis was performed in 77 children among which 16 (20.8%) had a severe bacteraemia. Non-
urinary-source bacteraemia (OR = 0.01, 95%CI = 0.001-Ϭ.ϭͿ aŶd ďeiŶg чϯ-month-old (OR = 7.7, 95%CI 
= 1.4-42.8) were the only risk factors of severity. The c-statistic of the final model was 0.93 (95%CI = 
0.87-0.99). The p-value of the Hosmer-Lemeshow test was 0.93, showing no model misspecification. 
Among the ϰϯ ĐhildƌeŶ чϯ-month-old, the bacteraemia was severe in 14 (32.6%). Birth weight 
was lower (median [min-max] = 1560g [595-3580] vs. 3285g [910-5090], p<0.01) and a preterm birth 
was more frequent (71.4% vs. ϭϯ.ϴ%, p<Ϭ.ϬϬϭͿ iŶ чϯ-month-old children with severe bacteraemia. 
ChildƌeŶ чϯ-month-old with a severe bacteraemia had a more frequently non-urinary (92.9% vs. 
17.2%, p<0.001) but digestive (50.0% vs. 10.3%, p<0.01) portal of entry than those without. Because 
of some missing characteristics, the multivariate analysis was performed in 41 children among which 
13 (31.7%) had a severe bacteraemia. A non-urinary source of bacteraemia was the only risk factor 
associated with severity (OR = 72.0, CI95% = 7.2-796.9). Prematurity and birth weight were not found 
significantly associated with severity, nor any of the bacterial characteristics tested. The c-statistic for 
this final model was 0.89 (CI95% = 0.80-0.99). The p-value of the Hosmer-Lemeshow test was >0.99, 
showing no model misspecification. 
DISCUSSION 
Few data are available about E. coli bacteraemia in children despite its frequency and 
severity. To our knowledge, this is the first report combining bacterial and host characteristics in E. 
coli bacteraemia in children.  
We found a high proportion of strains belonging to the B2 and D phylogroups. Main clonal 
groups delineated from the B2 strains were the II and IX clonal groups, representing 23.8% each of all 
the strains. They correspond respectively to the STc73 and STc95 (8, 9). Strains belonging to STc131 
(clonal group I) accounted for 3.6% in our study. We found a high proportion of CGA (STc69) among 
the D phylogroup strains, which accounted for 8.3% of all strains. All these CGA strains were resistant 
to cotrimoxazole. These results are similar to those obtained in adults. In a study of 300 
uropathogenic E. coli, most common STc retrieved were STc73 (16.6%), STc131 (13.3%), STc69 (9%) 
and STc95 (6.3%) (29). We also observed a predominance of 4 specific O-types, i.e. O1, O2a/b, O6 
and O7. These data indicate that some specific clones among the huge clonal diversity of the E. coli 
species (4) are involved in extraintestinal infections. At the opposite, a high diversity in the pattern of 
presence or absence of virulence genes was evidenced, with 61 observed combinations (Table S1). 
Altogether, these data support the fact that extraintestinal virulence in E. coli is due to multiple 
combinations of virulence genes (6) arriving on specific genetic backgrounds (30). However, some 
specific virulence factors have been associated to specific syndromes. In their study of 123 children, 
Cheng et al. showed that E. coli strains causing urinary-source bacteraemia harboured more 
frequently papGI, iutA, traT, focG, afa, bmaE, kpsMT III, rfc and cvaL than strains causing acute 
pyelonephritis or acute lobar nephronia (16). Bonacorsi and colleagues found that, in infants younger 
than 90 days, the presence of hly and/or iroN, as was that of hly and/or antigen K1, was associated in 
strains causing urinary tract infections with bacteraemia (15). This group also found that, in young 
infants, papGII, sfa/foc and hly were more frequent in strains isolated from urosepsis than from 
meningitis (12, 13). Similarly, in a studǇ of ϭϬϬ iŶfaŶts чϯ-month-old with bacteraemia, these authors 
concluded that papGII and tcpC were more frequent, but ibeA less frequent, in E. coli originating 
from urinary tract infection than from gut translocation (17). In the same line, we found that iucC, 
which belongs to the aerobactin operon as iutA, and papGII were more frequent in urinary-source 
bacteraemia (Table 2). 
We took the opportunity of the large COLIBAFI cohort to compare community-acquired 
urinary-source bacteraemia between children and adults. We found that bacteraemia in children 
were less severe, but involved strains exhibiting a specific repertoire of virulence genes and being 
more resistant than those isolated in adults. Children are usually considered to be more susceptible 
to infections due to an immature immune system. This apparently contra intuitive result might be 
explained by comorbidities in the adult group (23.9% of adults were immunocompromized (14), and 
only 4.9% of children). To our knowledge, no study compared the prevalence of resistant bacteria in 
children and in adults. Data of the European Antimicrobial Resistance Surveillance Network for the 
period 2005 – 2007 show that about 55% of E. coli strains were resistant to aminopenicillins (31). The 
higher prevalence of resistance observed in our cohort of children (63.1%) might be explained by the 
difference in antibiotic consumption among children. In France in 2004, the number of antimicrobial 
prescriptions for respiratory infections was almost 3 times higher in infants <2.5-year-old than in 
adults (32). This suggests that children have a higher selective pressure than adults, which could 
result in higher rates of infection with resistant bacteria. 
In our study, we found a case-fatality rate of 9.5%, similar to that observed in a cohort of 
2300 E. coli bacteraemia in Canada (2). No bacterial characteristic was associated with severity 
defined as death or transfer to ICU during follow-up. The severity outcome was driven by portal of 
entry and age. This observation was also made in adults, in whom we showed that host factors and 
the portal of entry outweighed bacterial determinants for predicting death from E. coli bacteraemia  
(14). HoudouiŶ et al. eǆaŵiŶed patieŶts’ ĐhaƌaĐteƌistiĐs aŶd ďaĐteƌial ǀiƌuleŶĐe ŵeĐhaŶisŵs iŶ lethal 
and non-lethal E. coli meningitis (27). In theiƌ ƌetƌospeĐtiǀe studǇ of ϵϵ ĐhildƌeŶ чϯ-month-old, no 
pre-onset clinical factor was significantly associated with a fatal outcome. The only bacterial 
characteristic significantly associated with lethality was the absence of the aerobactin gene iucC. 
However, no multivariate analysis was performed. 
Our study has several limitations. First, our prospective cohort included a rather small 
number of children. Bacteraemia was severe only in 17 children, thus diminishing the power to 
determine risk factors of severity. However, we obtained a model with good predictive capacity (c-
statistic of 0.93). Second, our study was performed in 2005 – 2007. Only 3 strains resistant to third 
generation cephalosporins were isolated. In the recent years, the prevalence of resistant bacteria has 
increased. A study performed in Sweden in 2010 showed that 2.9% of healthy children were 
colonized with extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae. This figure 
rose to 8.4% in ill children (33). This could weaken our results, as bacteraemia due to ESBL-producing 
E. coli have been associated with an increased risk of mortality in adults (34). Despite these 
limitations, our multicenter study with a prospective design is the first one focusing on E. coli 
bacteraemia in children. Further studies should be performed on larger cohorts to confirm our 
findings.  
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TABLE 1. Clinical and bacteriological characteristics of the 84 children with E. coli bacteraemia. 
Characteristic n [%]
1 
Age, median (min-max), months 2.4 (0-204) 
Males 48 [57.1] 
Nosocomial infection
2 
25 [30.1] 
Immunocompromized
2 
8 [10.4] 
Portal of entry
2
 
Urinary tract 51 [66.2] 
Digestive tract 15 [19.5] 
Respiratory tract 2 [2.6] 
Cutaneous 3 [3.9) 
Venous catheter 5 [6.5] 
Surgical site 1 [1.3] 
Not determined 7 [9.1] 
Two portals of entry 7 [9.1] 
Polymicrobial infection 3 [3.6] 
Phylogenetic group 
A 7 [8.3] 
B1 3 [3.6] 
B2 53 [63.1] 
C 3 [3.6] 
D 10 [11.9] 
F 8 [9.5] 
Antibiotic resistance 
Amoxicillin 53 [63.1] 
Amoxicillin + clavulanate 38 [45.2] 
Gentamicin 3 [3.6] 
Ofloxacin 3 [3.6] 
Cotrimoxazole 29 [34.5] 
3rd generation cephalosporins 3 [3.6] 
Multidrug resistance 3 [3.6] 
Resistance score, median (min-max) 1 (0-5) 
Virulence score, median (min-max) 12 (1-19) 
 
Notes:  
1
Except when otherwise notified. 
2
Because of missing data, percentages are calculated based on available data. 
TABLE 2. Characteristics of the E. coli isolates according to the portal of entry (urinary- vs. digestive- 
source bacteraemia). 
Characteristic 
n [%]
1
 
p 
Urinary tract (n=47) Digestive tract (n=11) 
Phylogenetic group 
B2 31 [66] 5 [45.5] 
0.3 
non-B2 16 [34] 6 [54.5] 
Extraintestinal virulence gene 
neuC (K1) 16 [34] 7 [63.6] 0.09 
sfa/soc 12 [25.5] 2 [18.2] >.99 
iroN 25 [53.2] 5 [45.5] 0.7 
iucC 42 [89.4] 5 [45.5] 0.003 
iha 25 [53.2] 4 [36.4] 0.5 
papC 39 [83] 7 [63.6] 0.2 
papGII 38 [80.9] 5 [45.5] 0.03 
papGIII 2 [4.3] 2 [18.2] 0.2 
hlyC 17 [36.2] 2 [18.2] 0.3 
cnf1 7 [14.9] 2 [18.2] >.99 
hra 26 [55.3] 6 [54.6] >.99 
sat 31 [66] 4 [36.4] 0.09 
ire 22 [46.8] 4 [36.4] 0.7 
usp 31 [66] 7 [63.6] >.99 
ompT 40 [85.1] 10 [90.9] >.99 
ibeA 2 [4.3] 2 [18.2] 0.2 
fyuA 45 [95.7] 10 [90.9] 0.5 
irp2 45 [95.7] 10 [90.9] 0.5 
traT 38 [80.9] 9 [81.8] >.99 
clbA 12 [25.5] 4 [36.4] 0.5 
clbQ 12 [25.5] 4 [36.4] 0.5 
Virulence score, median (min-max) 12 (1-18) 11 (3-15) 0.3 
PAI 
PAI ICFT073 14 [29.8] 0 [0] 0.05 
PAI IIJ96 7 [14.9] 2 [18.2] >.99 
PAI III536 12 [25.5] 2 [18.2] >.99 
PAI IV536 45 [95.7] 10 [90.9] 0.5 
PAIgimA 2 [4.3] 2 [18.2] 0.2 
PAIUSP 31 [66] 7 [63.6] >.99 
PAIpks 12 [25.5] 4 [36.4] 0.5 
PAI score, median (min-max) 2 (0-6) 2 (0-5) 0.8 
Antibiotic resistance 
Amoxicillin 34 [72.3] 6 [54.6] 0.3 
Gentamicin 1 [2.1] 0 [0] >.99 
Ofloxacin 2 [4.3] 0 [0] >.99 
Cotrimoxazole 19 [40.4] 4 [36.4] >.99 
3rd generation cephalosporins 1 [2.1] 0 [0] >.99 
Multidrug resistance 2 [4.3] 0 [0] >.99 
Resistance score, median (min-max) 1 (0-4) 1 (0-2) 0.3 
Notes:  
1
Except when otherwise notified. 
PAI, pathogenicity-associated island 
TABLE 3. BaĐteƌial ĐhaƌaĐteƌistiĐs iŶ the чϯ vs. >3-month-old groups. 
Characteristic 
n [%]
1
 
p ≤3-month (n=43) >3-month (n=41) 
Polymicrobial infection 2 [4.7] 1 [2.4] >.99 
Phylogenetic group 
B2 29 [67.4] 24 [58.5] 
0.5 
non-B2 14 [32.6] 17 [41.5] 
Extraintestinal virulence gene 
neuC (K1) 24 [55.8] 11 [26.8] 0.009 
sfa/foc 12 [27.9] 11 [26.8] >.99 
IroN 25 [58.1] 25 [61] 0.8 
iucC 34 [79.1] 36 [87.8] 0.4 
iha 24 [55.8] 17 [41.5] 0.2 
papC 37 [86] 30 [73.2] 0.2 
papGII 34 [79.1] 28 [68.3] 0.3 
papGIII 6 [14] 3 [7.3] 0.5 
hlyC 17 [39.5] 12 [29.3] 0.4 
cnf1 10 [23.3] 5 [12.2] 0.3 
hra 29 [67.4] 19 [46.3] 0.1 
sat 26 [60.5] 23 [56.1] 0.8 
ire 25 [58.1] 18 [43.9] 0.3 
usp 31 [72.1] 24 [58.5] 0.3 
ompT 39 [90.7] 32 [78] 0.1 
ibeA 3 [7] 2 [4.9] >.99 
fyuA 43 [100] 36 [87.8] 0.02 
irp2 43 [100] 36 [87.8] 0.02 
traT 36 [83.7] 29 [70.7] 0.2 
clbA 15 [34.9] 12 [27.9] 0.6 
clbQ 15 [34.9] 12 [27.9] 0.6 
Virulence score, median (min-max) 15 (5-18) 10 (1-19) 0.02 
PAI 
PAI ICFT073 12 [27.9] 9 [22] 0.6 
PAI IIJ96 10 [23.3] 5 [12.2] 0.3 
PAI III536 12 [27.9] 11 [26.8] >.99 
PAI IV536 43 [100] 36 [87.8] 0.02 
PAIgimA 3 [7] 2 [4.9] >.99 
PAIUSP 31 [72.1] 24 [58.5] 0.3 
PAIpks 15 [34.9] 12 [27.9] 0.6 
PAI score, median (min-max) 3 (1-16) 2 (0-7) 0.1 
Antibiotic Resistance 
Amoxicillin 22 [51.2] 31 [75.6] 0.02 
Gentamicin 1 [2.3] 2 [4.9] 0.6 
Ofloxacin 1 [2.3] 2 [4.9] 0.6 
Cotrimoxazole 10 [23.3] 19 [46.3] 0.04 
3rd generation cephalosporins 1 [2.3] 2 [4.9] 0.6 
Multidrug resistance  1 [2.3] 2 [4.9] 0.6 
Resistance score, median (min-max) 1 (0-4) 1 (0-5) 0.01 
Notes:  
1
Except when otherwise notified. 
PAI, pathogenicity-associated island. 
TABLE 4. Clinical and bacterial characteristics in children and adults with community-acquired 
urinary-source bacteraemia. 
Characteristic 
n [%]
1
 
p 
Children (n=45)  Adults (n=513)  
Clinical 
Female 20 [44.4] 375 [73.1] <0.001 
Immunocompromized
2
 2 [4.9] 120 [23.9] 0.003 
Transfer to ICU 0 [0] 35 [6.9] 0.1 
Death 0 [0] 33 [6.4] 0.1 
Severe bacteraemia
3
 0 [0] 61 [11.9] 0.01 
Bacterial 
Polymicrobial infection 1 [2.2] 11 [2.1] >.99 
Phylogenetic group 
B2 29 [64.4] 322 [62.8] 
0.9 
non-B2 16 [35.6] 191 [37.2] 
Virulence factor 
neuC (K1) 15 [33.3] 138 [26.9] 0.4 
sfa/foc 12 [26.7] 154 [30.0] 0.7 
IroN 25 [55.6] 315 [61.4] 0.4 
iucC 41 [91.1] 367 [71.6] 0.004 
iha 24 [53.3] 185 [36.1] 0.03 
papC 37 [82.2] 345 [67.3] 0.04 
papGII 36 [80.0] 288 [56.3] 0.02 
papGIII 2 [4.4] 63 [12.3] 0.1 
hlyC 17 [37.8] 173 [33.7] 0.6 
cnf1 7 [15.6] 119 [23.2] 0.3 
hra 24 [53.3] 354 [69.0] 0.04 
sat 30 [66.7] 191 [37.2] <0.001 
ire 20 [44.4] 202 [39.4] 0.5 
usp 29 [64.4] 324 [63.1] >.99 
ompT 38 [84.4] 398 [77.6] 0.3 
ibeA 2 [4.4] 29 [5.7] >.99 
fyuA 43 [95.6] 438 [85.4] 0.07 
irp2 43 [95.6] 440 [85.8] 0.07 
traT 36 [80.0] 338 [65.9] 0.07 
Virulence score, median (min-max) 11 (1-16) 11 (0-17) 0.1 
PAI 
PAI ICFT073 14 [31.1] 102 [19.9] 0.09 
PAI IIJ96 7 [15.6] 119 [23.2] 0.3 
PAI III536 12 [26.7] 152 [29.6] 0.7 
PAI IV536 43 [95.6] 438 [85.4] 0.07 
PAIgimA 2 [4.4] 29 [5.7] >.99 
PAIUSP 29 [64.4] 324 [63.2] >.99 
PAI score, median (min-max) 2 (0-5) 1 (0-4) <0.001 
Resistance to 3rd generation cephalosporins 1 [2.2] 15 [2.9] >.99 
Multidug resistance 2 [4.4] 38 [7.4] 0.8 
Resistance score, median (min-max) 1 (0-4) 1 (0-5) 0.04 
 
Notes:  
1
Except when otherwise notified. 
2
Because of missing data, percentages are calculated based on available data 
PAI, pathogenicity-associated island. 
3
Death or transfer to ICU. 
TABLE 5. Risk factors of severity (transfer in ICU or death) from E. coli bacteraemia identified by 
univariate and multivariate analysis in all included children. 
Risk factor 
n [%] Univariate analysis Multivariate analysis
2
  
Severity 
OR (IC 95%) p OR (IC 95%) p 
no  
(n =67)  
yes 
 (n =17)  
Clinical 
Younger than 3 months 29 [43.3] 14 [82.4] 6.1 (1.6 - 23.3) 0.008 7.7 (1.4 - 42.8) 0.02 
Nosocomial infection
1
 17 [25.8] 8 [47.1] 2.6 (0.9 - 7.7) 0.09   
Portal of entry
1 
Urinary tract 50 [82.0] 1 [6.2] 0.01 (0.002 - 0.1) <0.001 0.01 (0.001 - 0.1) <0.001 
Digestive tract 8 [13.1] 7 [43.7] 5.2 (1.5 - 17.7) 0.009   
Venous catheter 2 [3.3] 3 [18.7] 6.8 (1.0 - 44.9) 0.05   
Not determined 3 [4.9] 4 [25.0] 6.4 (1.3 - 32.6) 0.02   
Bacterial 
Resistance to amoxicillin 45 [67.2] 8 [47.1] 0.4 (0.2 - 1.3) 0.1   
Resistance to 3rd 
generation cephalosporins 
1 [1.5] 2 [11.8] 8.8 (0.8 - 103.5) 0.08 
  
Resistance to gentamicin 1 [1.5] 2 [11.8] 8.8 (0.8 - 103.5) 0.08   
B2 Phylogenetic group 42 [62.7] 11 [64.7] 1.1 (0.4 - 3.3) 0.9   
Virulence factor 
neuC (K1) 24 [35.8] 11 [64.7] 3.3 (1.1 - 10.0) 0.04   
iucC 59 [88.1] 11 [64.7] 0.3 (0.1 - 0.9) 0.03   
ire 31 [46.3] 12 [70.6] 2.8 (0.9 - 8.8) 0.08   
clbA 18 [26.9] 9 [52.9] 3.1 (1.0 – 9.1) 0.08   
clbQ 18 [26.9] 9 [52.9] 3.1 (1.0 – 9.1) 0.08   
 
Note:  
1
Because of missing data, percentages are calculated based on available data. 
2
Because of missing characteristics, the multivariate analysis was performed in 77 children. 
 
